Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Tradjenta - Treatment for Type II Diabetes



Linagliptin (BI-1356) is an orally medicated drug for the treatment of type-II diabetes.


Back to Project Details



Related Projects

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

See all projects


Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.